Alternatives to GeneSort

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Advanced diagnostics for preventative health and personalized cancer treatment using AI and genomics.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Bioinformatics platform for rapid discovery and validation of precision mental health treatments.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.

Biotechnology company personalizing medical cannabis treatment using metabolic biomarker analysis.

Unleashing the power of genomics at scale for biological advances and human health.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

BioControl develops advanced diagnostic solutions for infectious diseases and cancer.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A vertically-integrated procurement platform for the life sciences industry.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Provides AI-powered data analysis solutions for molecular diagnostics and research, streamlining qPCR data interpretation.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

AI-powered blood test for early cancer detection and subtyping.

Revolutionizing genomic analysis with innovative sequencing technology.

AI-driven predictive modeling company focused on biology and life sciences.

Establishing the first comprehensive database of healthy pediatric tissue gene expression to understand genetic influences on childhood development and diseases.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

AI platform for discovering complex multi-omics signatures for personalized medicine.

A leading children's research hospital dedicated to treating and curing childhood catastrophic diseases.

Develops a computational model of the human body for drug discovery and development.

Building General Biological Intelligence

Patient-controlled health data platform for record consolidation and research sharing.

AI-enabled technology for cell biology research and biopharma development.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered spatial biology platform for precision medicine and drug development.

Connects patients, providers, pharmacies, and life science companies to improve treatment affordability.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

Develops precision proteins for impact nutrition using proteomics and bioinformatics.

Personalized nutrition and metabolic health platform using gut microbiome and AI.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Personalized diagnostics for cancer genomic markers at the point of treatment.

Develops AI-driven, real-time intraoperative imaging for early lung cancer diagnostics and treatment.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Cloud platform for secure sharing and analysis of real-world health data for life sciences.

Health Behavior Management platform enabling health plans to improve outcomes and reduce costs.

Sweetch is a digital therapeutics company leveraging AI and emotional intelligence for hyper-personalized patient engagement.